DNA

CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer

The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients…

1 year ago

Accelerating Demand for Specialized RCM Solutions in Outpatient and Ancillary Services Set to Surge in 2025, Reports Black Book Research

The U.S. healthcare revenue cycle management (RCM) outsourcing market for outpatient and ancillary services is experiencing significant growth. In 2023,…

1 year ago

90+ CELLARS LAUNCHES NON-ALCOHOLIC SPARKLING WINES

With Growing Demand in Zero Proof and Bubbly Drinks, New Dealcoholized Sparkling Brut and Sparkling Rosé Hit the Spot BOSTON,…

1 year ago

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions…

1 year ago

Dr. Drew Features Nuvia’s Permanent Teeth in 24 Hours Process

SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Nuvia Dental Implant Centers, a national leader in advanced dental implant solutions,…

1 year ago

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and…

1 year ago

Stride Autism Centers Appoints Emily Patrizi as Chief Operating Officer

Leading Company Focused on ABA Therapy for Preschool Children with Autism Expands Leadership TeamCHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) --…

1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) --…

1 year ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial…

1 year ago